医院手术量与非肌层浸润性膀胱癌根治性膀胱切除术后死亡率相关
该研究基于荷兰癌症登记处2008至2018年9287例根治性膀胱切除术患者数据,评估医院手术量与术后30天和90天死亡率的关系。调整年龄、TNM分期和新辅助治疗后,术后死亡率在年手术量0至25例间略升,自30例起持续下降,最高手术量组风险最低。作者认为年手术量标准或应高于30例,并重新考虑EAU指南推荐的20例标准。
要点
- 根治性膀胱切除术后30天死亡率为2.2%,90天死亡率为5.6%。
- 调整混杂因素后,年手术量自30例起术后死亡率持续下降。
- 年手术量超过30例或可进一步降低术后死亡率。
核心结论
- 基于全国人群队列的高质量数据,年根治性膀胱切除术量超过30例或可进一步降低术后死亡率。
- 欧洲泌尿外科学会指南推荐的年手术量20例标准可能需重新考虑。
研究设计与样本
- 回顾性队列研究,数据来自荷兰癌症登记处2008年1月1日至2018年12月31日。
- 纳入9287例接受根治性膀胱切除术的膀胱癌患者。
- 医院手术量按患者手术前12个月内同院手术例数计算,以消除日历年影响。
- 采用逻辑回归结合非线性样条函数分析医院手术量与30天和90天死亡率的关系,并调整年龄、TNM分期和新辅助治疗。
主要发现
- 9287例患者中,医院手术量中位数(四分位距;范围)为19(12-27;1-75)例。
- 208例(2.2%)在术后30天内死亡,518例(5.6%)在术后90天内死亡。
- 调整年龄、TNM分期和新辅助治疗后,术后死亡率在医院手术量0至25例之间略有上升,自30例起持续下降。
- 最高手术量组的术后死亡风险最低。
临床怎么用
- 临床可参考年根治性膀胱切除术量作为评估术后死亡风险的因素之一。
- 年手术量超过30例的中心可能具有更低的术后死亡率,可考虑作为转诊或中心化管理的参考。
局限性
- 回顾性研究设计,可能存在残余混杂。
- 仅基于荷兰全国数据,外推至其他医疗体系需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To contribute to the debate regarding the minimum volume of radical cystectomies (RCs) that a hospital should perform by evaluating the association between hospital volume (HV) and postoperative mortality. PATIENTS AND METHODS: Patients who underwent RC for bladder cancer between 1 January 2008 and 31 December 2018 were retrospectively identified from the Netherlands Cancer Registry. To create a calendar-year independent measure, the HV of RCs was calculated per patient by counting the RCs performed in the same hospital in the 12 months preceding surgery. The relationship of HV with 30- and 90-day mortality was assessed by logistic regression with a non-linear spline function for HV as a continuous variable, which was adjusted for age, tumour, node and metastasis (TNM) stage, and neoadjuvant treatment. RESULTS: The median (interquartile range; range) HV among the 9287 RC-treated patients was 19 (12-27; 1-75). Of all the included patients, 208 (2.2%) and 518 (5.6%) died within 30 and 90 days after RC, respectively. After adjustment for age, TNM stage and neoadjuvant therapy, postoperative mortality slightly increased between an HV of 0 and an HV of 25 RCs and steadily decreased from an HV of 30 onwards. The lowest risks of postoperative mortality were observed for the highest volumes. CONCLUSION: This paper, based on high-quality data from a large nationwide population-based cohort, suggests that increasing the RC volume criteria beyond 30 RCs annually could further decrease postoperative mortality. Based on these results, the volume criterion of 20 RCs annually, as recently recommended by the European Association of Urology Guideline Panel, might therefore be reconsidered.
引用
- Richters A, Ripping TM, Kiemeney LA, et al. Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer. BJU Int. 2021. PMID: 33404154. doi:10.1111/bju.15334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。